Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
08/2012
08/29/2012EP2491030A1 Fused ring analogues of anti-fibrotic agents
08/29/2012EP2491018A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
08/29/2012CN102652462A Method for manufacturing organic electroluminescent element, organic electroluminescent element, display device and illuminating device
08/29/2012CN102652128A 4 -oxo- iH -quinoline- 3 - carboxamides as modulators of ATP -binding cassette transporters
08/29/2012CN101870696B N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
08/29/2012CN101638381B Synthesis method of montelukast sodium intermediate
08/29/2012CN101321742B Compositions and methods of treating retinal disease
08/29/2012CN101172966B Method for producing aripiprazole crystallite
08/28/2012US8252933 2-oxo-1,2-dihydro-quinoline modulators of immune function
08/28/2012US8252932 Modified carbocyanine dyes and their conjugates
08/28/2012US8252813 Salt and crystalline forms thereof of a drug
08/28/2012US8252530 Aza-benzazolium containing cyanine dyes
08/28/2012CA2402352C Fluorescent membrane intercalating probes and methods for their use
08/23/2012WO2012111021A1 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease
08/23/2012WO2012110858A1 Doped aluminum oxides
08/23/2012WO2012110857A1 Zinc chalcogenides, doped zinc chalcogenides, and methods of making
08/23/2012WO2012110833A2 Fluorescence modulators
08/23/2012WO2012110603A1 Novel sulfonaminoquinoline hepcidin antagonists
08/23/2012WO2012036520A3 Novel antibiotically active compound and an antibiotic composition comprising the compound
08/23/2012US20120215002 Synthesis of optically active intermediate for the preparation of montelukast
08/23/2012US20120214990 Quinolinones and quinoxalinones as antibacterial composition
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214803 Novel Sulfonaminoquinoline Hepcidin Antagonists
08/23/2012CA2826463A1 Novel sulfonaminoquinoline hepcidin antagonists
08/22/2012EP2489659A1 Modulators of ATP-binding cassette transporters
08/22/2012EP2488544A1 Affinity ligands and methods for protein purification
08/22/2012EP1888548B1 Quinoline derivative for the treatment of retinal diseases
08/22/2012EP1412326B1 Butyric acid derivatives
08/22/2012CN102648182A Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
08/22/2012CN102643230A 7-site substituted quinolone compound and application thereof in preparation of anti-tumor medicaments
08/22/2012CN102643207A 3-(2-naphthyl) acrylamide derivatives as well as preparation method and application thereof
08/22/2012CN101796030B Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide deritvatives
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012CA2569869C Collector for sulfidic ores
08/21/2012CA2552319C Hcv ns-3 serine protease inhibitors
08/16/2012WO2012109510A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
08/16/2012WO2012107532A1 4-aminoalcoholquinoline derivatives, enantioselective synthesis methods and the use thereof
08/16/2012US20120209003 METHODS FOR IDENTIFYING AND USING MarR FAMILY POLYPEPTIDE BINDING COMPOUNDS
08/16/2012US20120208989 Fluorinated aromatic materials and their use in optoelectronics
08/16/2012US20120208843 Method of Using GPR35 to Identify Metabolic-Stabilizing Compounds
08/16/2012US20120208840 Condensed Ring Pyridine Compounds As Subtype-Selective Modulators Of Sphingosine-1-Phosphate-2 (S1P2) Receptors
08/16/2012US20120208814 Thetrahydroquinolines Derivatives As Bromodomain Inhibitors
08/16/2012US20120208798 Tetrahydroquinoline Derivatives And Their Pharmaceutical Use
08/16/2012US20120208790 Ion channel modulators and methods of use
08/16/2012CA2826751A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
08/15/2012EP2487157A1 Enantioselective synthesis method of 4-aminoalcoholquinoline derivatives and the use
08/15/2012EP2486015A1 Sythesis of optically active intermediate for the preparation of montelukast
08/15/2012EP2485737A1 Novel trpa1 antagonists
08/15/2012EP2167469B1 Sulfonyl-quinoline derivatives
08/15/2012EP1898914B1 Quinoline derivatives as antibacterial agents
08/15/2012CN102633718A Preparation method of high-purity cinchocaine hydrochloride
08/15/2012CN102633717A N-acetyl-quinoline-2 (1H) ketone compounds as well as preparation method and application thereof
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633668A Use of compound in therapeutic drug for diseases related to disorder of transcription factor
08/15/2012CN102633590A Asymmetrical anthracene derivative and preparation method thereof
08/15/2012CN101847479B Microwave composite material and preparation method thereof
08/14/2012US8242251 Unsymmetrical cyanine dimer compounds and their application
08/14/2012US8242102 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
08/14/2012US8241852 Unsymmetrical cyanine dimer compounds and their application
08/09/2012WO2012106584A2 Pitavastatin salts
08/09/2012WO2012104659A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
08/09/2012WO2012024132A3 Solution-processable electron-transport materials and related organic optoelectronic devices
08/09/2012US20120202996 Tetrahydroquinoline derivatives
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/08/2012EP2483245A1 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
08/08/2012EP2200986B1 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
08/08/2012EP2132179B1 Process for preparing isomers of carmoterol
08/08/2012EP2089399B1 Polymerisation of ethylene and alpha olefins with single site catalysts having an anionic scorpion-like ligand
08/08/2012EP1838296B1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
08/08/2012CN102627603A Process of making crystalline aripiprazole
08/08/2012CN102267943B Method for preparing 5-chloro-8-hydroxyquinoline
08/07/2012US8236959 Process for preparing isomers of carmoterol
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236819 Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
08/07/2012US8236801 2-aza-bicyclo[2.2.1]heptane derivatives
08/07/2012US8236328 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers
08/02/2012WO2012101388A1 Novel azacoumarin derivatives having mdr pump inhibiting activity
08/02/2012WO2012101068A1 Novel tetrahydroquinoline derivatives
08/02/2012US20120197005 Containerless synthesis of amorphous and nanophase organic materials
08/02/2012US20120196994 Novel post metallocene-type transition metal compounds
08/02/2012US20120196894 Novel trpa1 antagonists
08/02/2012US20120196893 Composition, method, system and kit for optical electrophysiology
08/02/2012US20120196892 Novel caspase-2 inhibitors
08/02/2012CA2823804A1 Novel tetrahydroquinoline derivatives
08/01/2012EP1753421B1 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
08/01/2012EP1585757B1 Peptide deformylase inhibitors
08/01/2012CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102625798A Substituted quinolines for use as VEGF inhibitors
08/01/2012CN102625797A Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617463A Quinoline derivative and quinazoline derivative and preparation method thereof
08/01/2012CN102617462A Specificity inhibition muscle micro ribonucleic acid compound and synthesis method and application thereof
08/01/2012CN102617461A Novel method for refining aripiprazole
08/01/2012CN102617460A Compounding method of midbody required in compounding of montelukast sodium
08/01/2012CN102617456A Electron transporting-injection compound and organic electroluminescent device using the same
07/2012
07/31/2012US8232403 Bicyclic derivatives as CETP inhibitors
07/31/2012US8232402 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 277